Bri Heron, technology marketing manager at Indiana University’s Innovation and Commercialization Office, contributed the following story. In the United States alone, Alzheimer’s disease currently affects 6.5 million people and over 11 million caregivers. National costs are projected to reach $1 trillion by 2050. Current early detection approaches for Alzheimer’s disease and other forms of cognitive… Read more »
Tag: IU School of Medicine
Shining the spotlight on IU entrepreneurs, innovators
November is National Entrepreneurship Month in the U.S., a time when the nation celebrates its entrepreneurs and the contributions they make to strengthening the American economy and their communities. This week (Nov. 14-20) is also Global Entrepreneurship Week, an international celebration of entrepreneurship. Through robust educational programs and services in the areas of entrepreneurship, business… Read more »
Connecting capital to ideas and collaborating to ignite Indiana’s entrepreneurial ecosystem
For nearly two decades, Biocrossroads has established itself as a leader in helping to build Indiana’s life sciences sector and a major source of venture capital for Indiana-based life sciences startups. Biocrossroads has also been one of Indiana University’s most effective partners in helping to move laboratory discoveries into the marketplace and catalyzing a robust… Read more »
IU Ventures’ investment helps fuel continued growth of Indiana-based life sciences startup and newly named ‘Most Fundable’ company
The first-ever company to receive a double investment through IU Ventures’ startup support ecosystem, diagnostic cancer testing startup Amplified Sciences, just received some resounding support by way of one of the nation’s most rigorous startup competitions. Amplifed Sciences has landed on Pepperdine Graziadio Business School’s fourth-annual Most Fundable Companies List, which was announced during a… Read more »
Hepatitis B drug developed by Assembly Biosciences advances through early safety, tolerability, pharmacokinetic evaluation
Assembly Biosciences Inc., a Carmel-based biotech company with numerous ties to Indiana University and the Hoosier State — has successfully completed part of a Phase I study for a lead drug being developed to treat chronic cases of hepatitis B. The opening half of the study evaluated the safety, tolerability and pharmacokinetics (studies of how… Read more »
Several companies with IU ties among nominees for 18th annual Mira Awards
Nominees for TechPoint’s 18th annual Mira Awards were recently revealed, with half of the 180 applications received advancing in this year’s competition. The Miras honor the “Best of Tech” throughout Indiana and many of the nominees — as one might well imagine — have Indiana University ties. One such company, nominated for Innovation of the… Read more »
CREED members learn how art and design initiatives at Herron School make key contributions to local, regional and statewide economies
When the topic of economic impact is broached, art and design normally is not the first thing that comes to mind. But during their final meeting of 2016, members of IU’s Council for Regional Engagement and Economic Development (CREED) learned how the Herron School of Art + Design makes key economic contributions to their surrounding… Read more »
IU-backed startup appoints Steve Carchedi as new president and CEO
The month of October brought a flurry of events to ApeX Pharmaceuticals, a company co-founded by the IU School of Medicine’s Mark R. Kelley to develop novel compounds for cancer treatment. On Oct. 10, the company announced the appointment of Steve Carchedi as president and CEO. Formerly CEO of Cornerstone Pharmaceuticals, a biotech firm that… Read more »
McRobbie emphasizes internships, increased support for local and faculty-based startups during visit to IU South Bend campus
Indiana University President Michael A. McRobbie took to the rooftops of South Bend on Wednesday to spread a message he has carried throughout a statewide tour to IU campuses and their host cities throughout the past year. From the top of the city’s former Studebaker Corp. assembly building, which along with Union Station Technology Center… Read more »
Information sessions for Round Two of IU’s Grand Challenges research initiative scheduled for mid-October
Round Two of IU’s Grand Challenges program — a $300 million, multidisciplinary research effort to address “major and large-scale problems” faced by humanity — is now under way, with a Nov. 11 deadline fast approaching for scientific teams that wish to submit their preliminary proposals. For those who wish to learn more about the application… Read more »